Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report

Tekijä Wang, Tao, Wang, Ruimin, Dong, Zhouhuan, Liang, Naichao, Chang, Ping
Julkaisussa Open Med (Wars) (2016)

Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data anal...

Tekijä Chang, Nijia, Duan, Jingjing, Wang, Lingxiong, Dong, Zhouhuan, Liu, Zhefeng
Julkaisussa Oncol Lett (2020)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

Tekijä Wang, Tao, Liu, Yang, Zhou, Bin, Wang, Zhi, Liang, Naichao, Zhang, Yundong, Dong, Zhouhuan, Li, Jie
Julkaisussa Onco Targets Ther (2016)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

Tekijä Dong, Zhouhuan, Kong, Linghong, Wan, Zhiyi, Zhu, Fengwei, Zhong, Mei, Lv, Yali, Zhao, Po, Shi, Huaiyin
Julkaisussa Sci Rep (2019)

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer

Tekijä Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin
Julkaisussa Oncol Lett (2020)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma

Tekijä Lu, Yang, Luo, Guangda, Zhu, Songbiao, Wang, Xu, Chen, Yuling, Dong, ZhouHuan, Wang, Shiyu, Ma, Jie, Deng, Haiteng, Wu, Di, Dong, Jun
Julkaisussa Clin Proteomics (2020)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients

Tekijä Xue, Xinying, Asuquo, Idorenyin, Hong, Lei, Gao, Jie, Dong, Zhouhuan, Pang, Li, Jiang, Tianjiao, Meng, Mingming, Fan, Jingbo, Wen, Jiaxin, Deng, Hui, Zang, Xuelei, Ma, Xidong, Guo, Rui, Qin, Chong, Meng, Yao, Ma, Heji, Han, Jun, Wang, Haijiao, Xue, Zhiqiang, Zhao, Dahai, Lin, Dongliang, Pan, Lei
Julkaisussa Front Oncol (2020)